Teriparatide [rhPTH(1-34)] Increases Foot Bone Remodeling in Diabetic Chronic Charcot’s Neuroarthropathy: A Randomized, Double Blind, Placebo-Controlled Study

Journal of Diabetes - United States
doi 10.1111/1753-0407.12902
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Eptinezumab in Episodic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study (PROMISE-1)

Cephalalgia
MedicineNeurology
2020English

Visible Light-Induced Healing of Diabetic or Venous Foot Ulcers: A Placebo-Controlled Double-Blind Study

Photomedicine and Laser Surgery
Nuclear MedicineRadiologyBiomedical EngineeringImaging
2011English

Effects of Acebutolol on Chronic Stable Angina Pectoris. A Placebo- Controlled, Double-Blind, Randomized Crossover Study

Circulation
Cardiovascular MedicinePhysiologyCardiology
1980English

ADHD and EEG-neurofeedback: A Double-Blind Randomized Placebo-Controlled Feasibility Study

Journal of Neural Transmission
PsychiatryMental HealthNeurologyBiological Psychiatry
2010English

A Randomized, Double-Blind, Placebo-Controlled Pilot Study of a Probiotic in Emotional Symptoms of Chronic Fatigue Syndrome

Gut Pathogens
VirologyParasitologyInfectious DiseasesMicrobiologyGastroenterology
2009English

A Selective Neurokinin-1 Receptor Antagonist in Chronic PTSD: A Randomized, Double-Blind, Placebo-Controlled, Proof-Of-Concept Trial

European Neuropsychopharmacology
PsychiatryMental HealthNeurologyBiological PsychiatryPharmacology
2011English

Ghrelin Enhances Gastric Emptying in Diabetic Gastroparesis: A Double Blind, Placebo Controlled, Crossover Study

Gut
Gastroenterology
2005English

Different Inhaler Devices in Acute Asthma Attacks: A Randomized, Double-Blind, Placebo-Controlled Study

Jornal de Pediatria
Child HealthPediatricsPerinatology
2005English

A Phase 1 Randomized, Double Blind, Placebo Controlled Rectal Safety and Acceptability Study of Tenofovir 1% Gel (MTN-007)

PLoS ONE
Multidisciplinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy